2201 Westlake Avenue, Suite 200
Seattle, WA 98121
United States
PATH
Nipah virus, vaccine, randomised clinical trial, infectious diseases
Human papillomavirus (HPV), HPV vaccine, immunization, immunobridging, one-dose immunogenicity
SARS-CoV-2, COVID-19, Newcastle disease virus, Egg-based vaccine
SARS-CoV-2, COVID-19, Newcastle disease virus, Egg-based vaccine, Phase II clinical trial